04/15/2025 7:37 AM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/14/2025 11:15 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form EFFECT | |
04/14/2025 11:15 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form EFFECT | |
04/09/2025 6:20 PM | LENZ Therapeutics, Inc. (Issuer) LENZ Therapeutics (Issuer) Olsson Shawn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 3:05 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 424B3 | |
04/09/2025 3:06 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 424B3 | |
04/08/2025 11:15 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form EFFECT | |
04/08/2025 11:15 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form EFFECT | |
04/04/2025 3:45 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form POS AM | |
04/04/2025 3:46 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form POS AM | |
04/04/2025 3:48 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
Get the Latest News and Ratings for LENZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for LENZ Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
04/04/2025 3:53 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/19/2025 3:45 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/19/2025 3:38 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/07/2025 5:10 PM | LENZ Therapeutics, Inc. (Issuer) LENZ Therapeutics (Issuer) Schimmelpennink Evert B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 4:26 PM | LENZ Therapeutics, Inc. (Issuer) LENZ Therapeutics (Issuer) Olsson Shawn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 4:20 PM | LENZ Therapeutics, Inc. (Issuer) LENZ Therapeutics (Issuer) Schimmelpennink Evert B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 4:22 PM | Chevallard Daniel R. (Reporting) LENZ Therapeutics, Inc. (Issuer) LENZ Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 4:24 PM | LENZ Therapeutics, Inc. (Issuer) LENZ Therapeutics (Issuer) Odrich Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 6:55 PM | LENZ Therapeutics, Inc. (Issuer) LENZ Therapeutics (Issuer) Olsson Shawn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2024 4:08 PM | LENZ Therapeutics, Inc. (Subject) LENZ Therapeutics (Subject) Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
11/06/2024 7:03 AM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 424B3 | |
11/06/2024 7:06 AM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 424B3 | |
11/06/2024 6:35 AM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024 6:26 AM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/28/2024 7:23 AM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 424B3 | |
10/28/2024 7:24 AM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 424B3 | |
10/28/2024 7:09 AM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/19/2024 11:15 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form EFFECT | |
09/19/2024 4:04 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 424B3 | |
09/11/2024 3:09 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
08/14/2024 3:25 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 424B3 | |
08/12/2024 7:05 AM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/12/2024 7:11 AM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 424B3 | |
07/29/2024 3:12 PM | LENZ Therapeutics, Inc. (Subject) LENZ Therapeutics (Subject) Ridgeback Capital Investments L.P. (Filed by)
| Form SC 13G | |
07/23/2024 7:16 PM | LENZ Therapeutics, Inc. (Issuer) LENZ Therapeutics (Issuer) Schimmelpennink Evert B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/15/2024 7:32 AM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 424B3 | |
07/15/2024 7:22 AM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/21/2024 7:31 AM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/14/2024 4:29 PM | LENZ Therapeutics, Inc. (Issuer) LENZ Therapeutics (Issuer) MCCOLLUM JAMES W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 3:18 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 424B3 | |
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad) $2 trillion has disappeared from the US government's books.
The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth. Click here to see his new research now. |
05/08/2024 4:11 PM | LENZ Therapeutics, Inc. (Filer) LENZ Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |